Kobayashi Pharmaceutical Co Ltd
Kobayashi Pharmaceutical's Climate Target Data Preview
As of 2025, Kobayashi Pharmaceutical has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Kobayashi Pharmaceutical ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  a | 2030 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  a | 2030 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Kobayashi Pharmaceutical’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Kobayashi Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Kobayashi Pharmaceutical's Greenhouse Gas Emissions Pathways
As of 2025, Kobayashi Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint. a
Does Kobayashi Pharmaceutical have a target to reduce the emissions from its operations?
As of 2025, Kobayashi Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources. a
Kobayashi Pharmaceutical's most ambitious operational target is to reduce these emissions by 51% by 2030, compared to a baseline of 30,000 Metric Tonnes of CO2 equivalent (mtCO2e) in 2018. a
As of 2024, Kobayashi Pharmaceutical is lagging behind on its operational emissions reduction target, having achieved 19.61% of the planned reduction. a
Kobayashi Pharmaceutical's Operational (Scope 1+2) Emissions Pathway
Does Kobayashi Pharmaceutical have a target to reduce the emissions from its value chain?
As of 2025, Kobayashi Pharmaceutical has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol. a
Kobayashi Pharmaceutical's most ambitious value chain target is to reduce these emissions by 15% by 2030, compared to a baseline of 596,000 Metric Tonnes of CO2 equivalent (mtCO2e) in 2018. a
As of 2024, Kobayashi Pharmaceutical is ahead of schedule on its value chain emissions reduction target, having achieved 83.87% of the planned reduction. a